DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Flulaval (Influenza Virus Vaccine) - Current Clinical Trials

 
 



Flulaval Related Clinical Trials

School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities [Completed]

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults [Completed]

Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects [Completed]

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM [Completed]

A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 [Completed]

Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults [Completed]

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years [Completed]

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects [Completed]

Study of Quadrivalent Influenza Vaccine Among Adults [Completed]

A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults [Completed]

2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women [Completed]

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects [Completed]

Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation. [Completed]

A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age [Completed]

A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older [Completed]

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021)- Year 1, 2011 [Active, not recruiting]

Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study [Completed]

Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years [Completed]

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age [Completed]

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children [Completed]

Control of Epidemic Influenza Through a School-based Influenza Vaccination Program [Active, not recruiting]

Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy [Active, not recruiting]

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine [Active, not recruiting]

FluMist in Egg Allergic Patients [Recruiting]

Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza [Completed]

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children [Completed]

A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children [Completed]

Evaluate Reactogenicity and Immunogenicity of Standard-dose (SD) Versus High-dose (HD) Inactivated Influenza Vaccine Trivalent (IIV3) in Recipients of Solid Organ Transplants. [Recruiting]

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009 [Active, not recruiting]

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine [Completed]

Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants [Terminated]

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults [Completed]

Direct and Indirect Protection by Influenza Vaccine Given to Children in India [Completed]

Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03) [Active, not recruiting]

Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant [Completed]

Influenza Vaccine in Pregnant Women [Completed]

Direct and Indirect Benefits of Influenza Vaccination in Schools and Households [Completed]

Study of Quadrivalent Influenza Vaccine Among Children [Completed]

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine [Completed]

Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza [Completed]

Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control [Completed]

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults [Completed]

Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young Children [Completed]

Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season [Recruiting]

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation) [Completed]

Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old [Completed]

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age [Completed]

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults [Completed]

Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects [Completed]

Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting [Completed]

Safety Study of FluMist With and Without Ampligen [Recruiting]

Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents [Completed]

Trial to Collect Safety Data and Sera for Immunogenicity Testing [Completed]

Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal [Completed]

Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A [Completed]

Brief Influenza Vaccine Education to Pregnant Women [Active, not recruiting]

Maternal Flu Vaccine Trial in Bamako, Mali [Active, not recruiting]

Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix [Completed]

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older [Completed]

Seasonal Influenza Vaccine Effectiveness Study in Kenya [Recruiting]

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV [Completed]

Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children [Completed]

Field Trial of Maternal Influenza Immunization in Asia [Recruiting]

Impact of Influenza Vaccination in Pregnancy Video Education [Completed]

Influenza Vaccine in HIV Infected Children [Completed]

Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects [Completed]

Influenza Immunization of Children in India [Active, not recruiting]

The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis [Recruiting]

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly [Completed]

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above [Completed]

Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A) [Completed]

Immune Responses to the Flu Shot During Pregnancy [Recruiting]

Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents [Enrolling by invitation]

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth [Completed]

Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60) [Completed]

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345 [Completed]

A Phase 2 Study to Evaluate Immune Responses of FluMist® [Completed]

Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017